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The dynamin-related GTPase OPA1 is mutated in autosomal dominant optic atrophy (DOA) (Kjer type), an
inherited neuropathy of the retinal ganglion cells. OPA1 is essential for the fusion of the inner mitochondrial
membranes, but its mechanism of action remains poorly understood. Here we show that OPA1 has a low
basal rate of GTP hydrolysis that is dramatically enhanced by association with liposomes containing nega-
tive phospholipids such as cardiolipin. Lipid association triggers assembly of OPA1 into higher order oligo-
mers. In addition, we find that OPA1 can promote the protrusion of lipid tubules from the surface of
cardiolipin-containing liposomes. In such lipid protrusions, OPA1 assemblies are observed on the outside
of the lipid tubule surface, a protein-membrane topology similar to that of classical dynamins. The membrane
tubulation activity of OPA1 is suppressed by GTPgS. OPA1 disease alleles associated with DOA display
selective defects in several activities, including cardiolipin association, GTP hydrolysis and membrane tubu-
lation. These findings indicate that interaction of OPA1 with membranes can stimulate higher order assem-
bly, enhance GTP hydrolysis and lead to membrane deformation into tubules.
INTRODUCTION
Three large GTPases are required for mitochondrial fusion,
which involves the coordinated fusion of both outer and
inner membranes (1). Outer membrane fusion requires the
mitofusins Mfn1 and Mfn2, integral membrane proteins of
the mitochondrial outer membrane (2). Inner membrane
fusion requires the inner membrane protein OPA1 (2), which
shows strong sequence similarity to dynamins. OPA1 is pro-
teolytically processed into inner membrane-bound long iso-
forms and soluble short isoforms. A combination of both
long and short isoforms is necessary for mitochondrial
fusion (3,4). In the absence of OPA1, outer membrane
fusion occurs without inner membrane fusion (2). Similar
results are observed with the yeast OPA1 ortholog Mgm1p
(5). In addition to mitochondrial fusion, OPA1/Mgm1p is
also required for the maintenance of cristae (5–9), extensive
infoldings of the mitochondrial inner membrane. However,
Dmgm1 yeast cells have normal cristae structure if mitochon-
drial fission is also disrupted (9).
Mutations in OPA1 cause dominant optic atrophy (DOA,
Kjer type), a degeneration of the optic nerve caused by loss
of retinal ganglion cells (10–12). Over 200 mutations in
OPA1 have been associated with DOA, but the effects of
these mutations on OPA1 remain poorly understood, in part
because little is known about the biochemistry of OPA1.
OPA1 belongs to the dynamin family, which consists of
large GTPases that are centrally involved in several important
membrane remodeling processes (13–15). Classical dyna-
mins, exemplified by dynamin-1, act as mechanochemical
enzymes that mediate the severing of endocytic vesicles
from the cell membrane. In the late stages of clathrin-mediated
endocytosis, dynamin-1 assembles on the outer surface of the
collar of an invaginating vesicle and facilitates its fission from
the cell membrane. In contrast, OPA1 mediates the topologi-
cally opposite process of membrane fusion.
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To better understand OPA1 function, we purified recombi-
nant OPA1 and developed assays to study its GTP hydrolysis
activity and association with lipids. In addition, we studied
whether these activities were perturbed by mutations in
OPA1 that cause DOA. Our results show that several OPA1
activities—including lipid association, GTP hydrolysis and
membrane tubulation—are disrupted in DOA disease alleles.
RESULTS
Cardiolipin enhances GTPase hydrolysis by OPA1
To study the biophysical properties of OPA1, we expressed the
short isoform of human OPA1 (splice form 1; termed hereafter
as OPA1-S1) with an N-terminal hexahistidine tag in bacteria.
Recombinant OPA1-S1 is highly soluble in 300 mM NaCl
(Fig. 1A) but shows low GTP hydrolysis activity, with a turn-
over number of 0.06 GTP/min (Fig. 1B). As the concentration
of NaCl is reduced, OPA1-S1 shows a modest increase in GTP
hydrolysis activity, reaching a maximum turnover number of
0.6 GTP/min at 0 mM salt (Fig. 1B). No GTP hydrolysis
activity was detected with OPA1-S1 containing the mutation
G300E in the G1 motif of the GTPase domain, indicating
that the low levels of GTP hydrolysis detected are authentic.
Concomitant with the 10-fold increase in GTPase activity
with decreasing salt, we found OPA1-S1 could be progress-
ively sedimented by a high-speed spin (100 000g). Whereas
little OPA1-S1 is sedimented at 300 mM NaCl, OPA1-S1
was found almost entirely in the pellet fraction at 50 and
0 mM salt (Fig. 1A). We examined OPA1 under various salt
conditions by negative staining electron microscopy and
found that the protein aggregates induced under low salt had
no specific or ordered morphology (Supplementary Material,
Fig. S1A). However, as shown later, these aggregates are
reversible and can functionally assemble onto lipid mem-
branes.
Because OPA1 is associated with the mitochondrial inner
membrane, we tested the effect of lipids on OPA1-S1 behav-
ior. Using a liposome co-sedimentation assay, we found no
interaction of OPA1-S1 with liposomes composed of phospha-
tidylcholine (POPC), or a mixture of POPC and phosphatidy-
lethanolamine (POPE) (Fig. 2A). A unique feature of
mitochondrial inner membranes is the high concentration of
cardiolipin, a negatively charged lipid that constitutes almost
20% by weight of the total lipid (16). We found that recombi-
nant OPA1-S1 co-sediments robustly with liposomes contain-
ing 25% cardiolipin (Fig. 2A). This association had a profound
effect on the GTP hydrolysis rate of OPA1, resulting in a
100-fold increase in the turnover number to 8 GTP/min
(Fig. 2B). The association of OPA1 with cardiolipin-
containing liposomes also correlated with its assembly into
higher order oligomers that can be detected with the homobi-
functional crosslinker bis(sulfosuccinimidyl)suberate
(Fig. 2C).
Because cardiolipin is an acidic phospholipid, we tested
other acidic phospholipids (Fig. 2A). We found that
OPA1-S1 associates strongly with liposomes containing 25%
phosphatidic acid (POPA) or 25% phosphoserine (POPS),
and these interactions also enhance GTP hydrolysis
(Fig. 2B). These results suggest that OPA1-S1 associates
with negatively charged phospholipids. However, given that
cardiolipin is by far the major negatively charged lipid in
the mitochondrial inner membrane (PI constitutes 5% and
POPS ,0.1%) (16), cardiolipin may be the physiological
lipid that regulates OPA1 activity.
Membrane tubulation by OPA1
Given the association of OPA1 with artificial liposomes and
the ability of dynamin family members to deform membranes,
we tested whether this association resulted in changes in
membrane structure. We prepared large multilamellar lipo-
somes that contain a lipid composition (45% POPC, 22%
POPE, 8% PI, 25% cardiolipin) approximating that of the
mitochondrial inner membrane. To visualize the liposomes,
3,3′-dioctadecyloxacarbocyanine (DiO) and biotin were incor-
porated, and the fluorescent liposomes were immobilized via
biotin–streptavidin interactions within a flow cell. Liposome
morphology was monitored with and without the addition of
OPA1-S1 into the flow cell.
Remarkably, addition of OPA1-S1 in the absence of
guanine nucleotides resulted in the protrusion of multiple,
thin lipid tubules from the liposome surface (Fig. 3B and
D). Such protrusions were often .5 mm in length. In addition
to liposome tubulation, we also observed an increase in the
number of liposomes with deformed surfaces with the addition
of OPA1-S1 (Fig. 3B and D and Supplementary Material,
Fig. S3). Because liposome tubulation is a more clearly
defined morphological category, we consider it to be a more
Figure 1. Stimulation of OPA1-S1 GTPase activity by low-salt and liposome
binding. (A) Sedimentation of OPA1-S1 under varying salt concentrations.
OPA1-S1 was dialyzed against the indicated concentration of NaCl and cen-
trifuged at 100 000g. The supernatant and pellet were analyzed by SDS–
PAGE. S, supernatant; P, pellet. (B) GTP hydrolysis activity of wild-type
and G300E OPA1 under varying salt concentrations. GTP hydrolysis was
measured at 100 mM GTP with the indicated NaCl concentration.
2114 Human Molecular Genetics, 2010, Vol. 19, No. 11
 at California Institute of Technology on M







definitive measure of OPA1 activity. By morphologically
scoring liposome reactions, we could quantify the ability of
OPA1 to tubulate membranes (Fig. 3D). Using time-lapse
microscopy, we observed real-time extension of long tubules
from liposome surfaces for up to 30 min (Fig. 3G and Sup-
plementary Material, Video S1). Liposome deformation and
tubulation events were not observed in the absence of
OPA1-S1 (Fig. 3A) or with neutrally charged liposomes and
OPA1-S1 (Fig. 3C).
We found that guanine nucleotides had a profound effect on
the ability of OPA1-S1 to tubulate cardiolipin-containing lipo-
somes. Pre-incubation of OPA1-S1 with GTPgS strongly
inhibited liposome tubulation (Fig. 3E), reducing the percent
of tubulated liposomes from 36 to ,1% (P-value , 0.0001,
unpaired t-test). As expected, this effect was dependent on
the presence of Mg2+ (data not shown). No effect of OPA1-
mediated membrane tubulation was found with GDP or
GTP. We also found that the GTPase mutant G300E showed
liposome tubulation activity (Fig. 3F). In contrast to wild-type
OPA1, however, this mutant, which is not expected to bind
guanine nucleotides, was unaffected by incubation with
GTPgS. Taken together, these results indicate that GTP
hydrolysis is not necessary for membrane tubulation by
OPA1 and that the GTPgS-trapped form of OPA1 is incompe-
tent to tubulate membranes. We found that guanine nucleo-
tides modestly increased the solubility of OPA1 under
intermediate salt conditions (150 mM NaCl) and had no
effect on the ability of OPA1 to bind to liposomes (Sup-
plementary Material, Fig. S2).
We further examined the properties of these lipid tubules by
negative staining electron microscopy and cryo-electron
microscopy (Fig. 4). The lipid tubules were of variable diam-
eter, ranging from 50 to .100 nm. OPA1 was present on the
outer surface of the lipid tubules and assembled there into
ordered structures as judged by Fourier analysis (Fig. 4B).
OPA1 assembled not only in the tubulated portions of the lipo-
somes, but also on the non-tubulated portion (Fig. 4E). In
these reactions, patches of ordered protein, apparently free
of membranes, were also readily observed (Fig. 4F).
We also observed that OPA1 can dynamically change confor-
mation upon interaction with membranes. As noted earlier,
under low-salt conditions, OPA1 forms protein aggregates that
have no specific morphology (Supplementary Material,
Fig. S1A). However, addition of cardiolipin-containing lipo-
somes to such aggregates leads to the assembly of OPA1 onto
the liposome surface and membrane tubulation (Supplementary
Material, Fig. S1B). After the addition of liposomes, few of the
amorphous protein aggregates can be found, indicating that such
aggregates are reversible and competent for lipid binding,
assembly into arrays and membrane tubulation.
We also tested whether OPA1-S1 could mediate the fusion
of liposomes. When OPA1-S1 was added to a mixture of two
distinctly labeled cardiolipin-containing liposome prep-
arations, the liposomes were found to undergo extensive
aggregation, but no fusion was found either in the presence
and or in the absence of GTP (Fig. 3H). This aggregation
was dependent on lipid composition. No aggregation was
found when one of the liposome populations contained only
POPC, which does not associate with OPA1-S1 (Fig. 3I).
The ability of OPA1 to aggregate liposomes may reflect its
ability to form intermolecular complexes in trans, a property
that has been proposed to be important for its biological
activity (5,6).
Distinct functions of OPA1 are disrupted in DOA
disease alleles
Our biochemical assays indicate that OPA1 has a low basal
rate of GTP hydrolysis activity that is substantially enhanced
Figure 2. Association of OPA1-S1 with artificial lipsomes. (A) Selective
binding of OPA1-S1 to liposomes. OPA1-S1 was incubated with the indicated
liposomes, and the mixture was centrifuged at 100 000g to sediment the lipo-
somes. The sedimentation of OPA1-S1 was analyzed in 300 (top panel) and
150 mM NaCl (lower panel) by SDS–PAGE. S, supernatant; P, pellet; PC,
100% POPC; PE, 78% POPC, 22% POPE; PI, 70% POPC, 22% POPE, 8%
PI; CL, 45% POPC, 22% POPE, 8% PI, 25% cardiolipin; PA, 45% POPC,
22% POPE, 8% PI, 25% POPA; PS, 45% POPC, 22% POPE, 8% PI, 25%
POPS. Liposome binding was analyzed by centrifugation and SDS–PAGE.
(B) Enhancement of GTP hydrolysis activity of wild-type OPA1 by liposomes.
GTP hydrolysis was assayed at 100 mM GTP and 0.2 mg/ml liposome. All
experiments were performed with 0.2 mg/ml OPA1-S1 at pH 7.0. (C)
Higher order oligomers of OPA1 form upon interaction with cardiolipin-
containing liposomes. The composition of the liposomes and the presence of
the crosslinker (BS3) are indicated at the bottom. Arrows indicate distinct
species of OPA1 resolved by SDS–PAGE.
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Figure 3. Membrane tubulation and liposome aggregation by OPA1-S1. (A–C) Images of fluorescently labeled liposomes. Immobilized cardiolipin-containing
liposomes were incubated with buffer (A) or OPA1-S1 (B) and imaged by fluorescence microscopy after 30 min. In (C), PC liposomes were incubated with
OPA1-S1. In (B), the arrows indicate examples of the three categories of liposome morphologies. White arrows indicate normal round liposomes; green arrows
indicate liposomes with deformed borders but not clear tubulation; red arrows indicate liposomes with clear membrane tubulation. The concentration of
OPA1-S1 and liposomes were both 0.2 mg/ml. (D) Quantification of OPA1-S1-mediated membrane tubulation at the indicated concentrations of OPA1-S1 and
in the absence of guanine nucleotides. In the control, no protein was added. The ‘tubular’ category was defined as liposomes that contained one or more thin
tubular extensions of at least 1 mm in length. This category therefore consisted of liposomes that showed unambiguous tubulation. The ‘deformed’ category
was defined as liposomes that contained surface protrusions, but not meeting the tubular criteria. The ‘round’ category consisted of spherical liposomes with no
surface protrusions. An electron micrograph showing tubular and deformed liposomes is shown in Supplementary Material, Figure S3. In each of three independent
experiments, 200 liposomes were scored; error bars indicate standard deviations. (E) Effect of guanine nucleotides on liposome tubulation. OPA1 was incubated
with Mg2+ (control) or Mg2+ and the indicated guanine nucleotide prior to the addition to cardiolipin-containing liposomes. In each of three independent exper-
iments, more than 100 liposomes were scored; error bars indicate standard deviations. (F) Effect of guanine nucleotides on the GTPase mutant G300E was analyzed
at in (E). (G) Time-lapse observation of OPA1-S1-mediated membrane tubulation from a cardiolipin-containing liposome. Arrows indicate extension of a .5 mm
lipid tubule over the course of 30 min. The corresponding movie is shown in Supplementary Material, Video S1. (H and I) Liposome aggregation by OPA1-S1.
OPA1-S1 was added to a mixture of DiO-labeled cardiolipin-containing liposomes (green) and DiI-labeled cardiolipin-containing liposomes (red) (H), or a
mixture of DiO-labeled cardiolipin-containing liposomes and DiI¼1,1’-dioctadecyl-3,3,3’3’-tetramethylindocarbocyanine perchlorate-labeled PC liposomes (I).
In (I), note that only the cardiolipin-containing liposomes aggregate. The concentration of OPA1-S1 and liposomes were both 0.2 mg/ml. All scale bars are 5 mm.
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Figure 4. Electron microscopy of liposome tubulation. (A and B) Negative stain of OPA1-S1 reconstituted with liposomes mimicking the mitochondrial inner
membrane lipid. (A) A low magnification view showing OPA1-S1 tubular structures with diameters in the range of 50 to 150 nm. In (B), a higher magnification
view shows an individual membrane tubule with a periodic arrangement of OPA1-S1 on the lipid substrate. The inset represents the Fourier transform of a
segment of the displayed tube indicating molecular order mainly along the long axis of the tube. (C) Cryo-TEM image of vesicle preparations prior to the
addition of OPA1-S1. Frozen–hydrated vesicles appear as a mixture of unilamellar and multilamellar vesicles of varying diameters. (D) Cryo-TEM of the
vesicle preparation after the addition of OPA1-S1. OPA1-S1 reconstitutes into tubular structures with OPA1-S1 molecules decorating the surface of the lipid
tubules. (E) Negative stain of OPA1 mixed with liposomes, showing that OPA1 assembles on the tubular as well as non-tubular (arrow) portions of the liposome.
(F) Negative-stained preparation of an OPA1/liposome reaction, showing patches of OPA1 arrays. Scale bars: (A) 500 nm; (B and D) 50 nm; (C) 200 nm; (E and
F) 100 nm.
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by association with cardiolipin. In addition, OPA1-S1 is suffi-
cient to mediate membrane tubulation. To uncover whether
these properties are physiologically important, we studied a
panel of eight mutant alleles that cause DOA. Four of these
alleles are associated with classical DOA (G300E, N728K,
Q785R, L939), whereas the other four (G439V, S545R,
R445H, V910D) are associated with the more severe form
termed ‘OPA1 plus’ DOA, which includes multiple mtDNA
deletions in addition to the classical optic atrophy (17,18).
All eight alleles have reduced function in vivo when
expressed in OPA1-null mouse embryonic fibroblasts
(MEFs). OPA1-null MEFs have completely fragmented mito-
chondria due to loss of mitochondrial fusion in the face of
ongoing mitochondrial fission (2,4). Re-introduction of the
wild-type OPA1 gene (splice form 1), which produces both
a long and a short isoform (4), results in tubular mitochondria
in .50% of the cells (Fig. 5). In contrast, seven of the eight
disease alleles are completely defective in inducing any
tubular mitochondria, indicating a severe loss of mitochondrial
fusion activity. The mutant Q785R shows a partial
loss-of-function phenotype, resulting in some mitochondrial
tubulation in ,30% of expressing cells.
To understand the molecular basis of these severe in vivo
defects, we studied these alleles in vitro using the biochemical
assays detailed earlier (Figs 6 and 7 and Supplementary Material,
Fig. S4). Two alleles (V910D and L939P) were found to be
almost completely insoluble when expressed in bacteria (data
not shown), in contrast to wild-type OPA1-S1. These two
alleles likely have a folding defect and were not studied further.
In the remaining six disease alleles, we uncovered three
overlapping classes. The first class consists of the single
mutant Q785R, which has a severe defect in the binding of
lipids, including cardiolipin. This defect is reflected in its
inability to sediment with liposomes containing cardiolipin,
POPA, POPS or PI (Fig. 6A). Associated with this binding
defect, Q785R shows a complete loss of GTPase enhancement
by cardiolipin-containing liposomes (Fig. 6D). Importantly,
however, this mutant showed normal levels of basal GTPase
activity and normal levels of stimulation by assembly under
low-salt conditions, indicating that its GTPase domain is
intact (Fig. 6B and C). Consistent with its defect in lipid
binding, Q785R was unable to either tubulate or aggregate
liposomes (Fig. 7A, B and D).
The second and largest class of OPA1 mutants shows
defects in GTP hydrolysis. One mutant, G300E, has a com-
plete loss of GTP hydrolysis activity. It shows no basal
GTPase activity and no stimulation by low salt or lipids
(Fig. 6B–D). The other alleles with mutations in the
GTPase domain (G439V, S545R, R445H) show reduced
levels of GTP hydrolysis under low-salt and lipid-containing
conditions (Fig. 6C and D). All the GTPase mutants show
no detectable mitochondrial fusion activity when expressed
in OPA1-null MEFs (Fig. 5).
The third class of mutants shows a defect in membrane tubu-
lation activity. As mentioned earlier, Q785R has a complete
defect in membrane tubulation secondary to loss of lipid
binding. In addition, N728K shows reduced membrane tubula-
tion activity (Fig. 7A and C), even though this mutant retains
association with liposomes (Fig. 6A) and could aggregate lipo-
somes (Fig. 7D). Taken together, these studies suggest that lipid
binding, regulated GTP hydrolysis and membrane tubulation are
all likely to be important aspects of OPA1 function.
DISCUSSION
For mammalian OPA1 and the yeast Mgm1p, simultaneous
expression of both long and short isoforms is necessary for
mitochondrial membrane fusion (3,4). The only exception in
mammalian cells is during stress-induced mitochondrial
fusion, which, for unclear reasons, requires only a long
OPA1 isoform (19). The long isoforms are constitutively
embedded in the mitochondrial inner membrane due to an
amino-terminal transmembrane anchor. The long isoforms
have been shown to physically interact with short isoforms
(5,6), and such interactions in Mgm1 appear essential for
fusion (20,21). Our results indicate that the OPA1 short iso-
forms, which lack a transmembrane anchor, also have impor-
tant interactions with the mitochondrial inner membrane. We
find that OPA1-S1 can assemble on lipid surfaces, and this
interaction dramatically activates its GTP hydrolysis activity.
Because cardiolipin is the most abundant negatively charged
lipid of the mitochondrial inner membrane, it may be the phys-
iological lipid that regulates OPA1 activity, although we
cannot rule out that other less abundant lipids may regulate
OPA1 within a membrane microdomain. In this respect,
Figure 5. Mitochondrial fusion activity of OPA1 disease alleles. The indicated alleles of OPA1 were expressed in OPA1-null MEFs by retroviral transduction,
and mitochondrial morphology was scored using mitochondrially targeted DsRed. For each mutant, 100 cells were scored in each of three independent exper-
iments; error bars indicate standard deviations. Control cells were not transduced with retrovirus.
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OPA1 resembles recently described properties of Mgm1p
(20,22). This lipid interaction may serve to regulate OPA1
so that it is activated only when positioned properly with
regard to the cardiolipin-rich inner membrane.
In addition, we find that OPA1-S1 alone robustly tubulates
liposomes. Electron microscopy clearly indicates that
OPA1-S1 assembles on the outer surface of the tubular protru-
sions, resulting in a membrane topology that is similar to that
of classical dynamins. The diameter of the lipid tubules ranges
from 50 to 100 nm, larger than dynamin-decorated tubules but
in the same range as yeast Dnm1p tubules, which have a diam-
eter of 100 nm (23). The similarities of OPA1 to classical
dynamin is striking, given that these two proteins mediate topo-
logically opposite reactions—membrane fusion for OPA1
versus membrane fission for dynamin. We speculate that
OPA1 may protrude the mitochondrial inner membranes
towards each other during the fusion process. In contrast to
dynamins, however, the membrane-tubulating activity of
OPA1-S1 is inactive in the presence of GTPgS. This observation
suggests that the GTPase cycle may regulate the fusion activity
of OPA1 by controlling its interaction with the lipid membrane.
Importantly, we find that DOA disease alleles disrupt key
biochemical features of OPA1. We uncovered alleles that
specifically disrupt lipid binding, GTP hydrolysis and mem-
brane tubulation. These observations suggest that these activi-
ties are key to OPA1 function. Further analysis of DOA alleles
may further clarify physiologically important features of
OPA1.
MATERIALS AND METHODS
Recombinant OPA1-S1 expression and purification
cDNA corresponding to the short S1 isoform of OPA1 was
PCR-amplified from the template plasmid pMSCV/
OPA1-Isfm1 (4) and subcloned into the pET28a(+)
expression vector (Novagen, Madison, WI, USA). Disease
alleles were constructed in pET28a/OPA1-S1 through PCR
with primers encoding point mutations. Details of OPA1-S1
purification are provided in Supplementary Material, Text S1.
GTPase assay
GTPase reactions were performed with 0.2 mg/ml OPA1-S1 in
50 mM HEPES (pH 7.0), 1 mM dithiothreitol (DTT) and
varying NaCl concentrations. In experiments with liposomes,
Figure 6. Effects of DOA disease mutations in liposome-binding and GTP hydrolysis activity. (A) Liposome binding was measured by a liposome
co-sedimentation assay, as in Fig. 2A. (B–D) GTP hydrolysis activity was measured at 300 mM NaCl (B), 0 mM NaCl (C) and 300 mM NaCl with cardiolipin-
containing liposomes (D).
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the reactions contained 50 mM HEPES (pH 7.0), 300 mM
NaCl, 1 mM DTT and 0.2 mg/ml unilamellar liposomes. GTP
hydrolysis was quantified by monitoring the free phosphate
concentration using a malachite green assay (24). Reactions
were initiated by the addition of GTP to 100 mM and incu-
bation at 378C. Aliquots (10 ml) at regular time points were
quenched with 5 ml of 0.5 M EDTA at regular time points.
After the addition of malachite green solution to 750 mM, the
free phosphate concentration was monitored by absorbance
at 650 nm in a 96-well plate reader (Infinite M200 TECAN,
Durham, NC, USA). Details of liposome preparation, as well
as the liposome tubulation and aggregation assays are pro-
vided in Supplementary Material, Text S1.
Sedimentation assay
OPA1-S1 was dialyzed at 48C overnight against varying con-
centrations of NaCl (0 to 300 mM) in 50 mM HEPES (pH 7.0)
and 1 mM DTT and diluted to a concentration of 0.2 mg/ml.
For the assembly of OPA1-S1 on liposomes, all liposomes
were extruded 15 times through a 1 mm polycarbonate filter
using a LiposoFast extruder (Avestin, Ottawa, Canada). The
Figure 7. Effects of DOA disease mutations on membrane tubulation and liposome aggregation. (A) Quantification of membrane tubulation by mutant alleles at
0.4 mg/ml, scored as in Fig. 3D. (B) Quantification of membrane tubulation by Q785R at varying concentrations. (C) Quantification of membrane tubulation by
N728K. In (A–C), 200 liposomes were scored in each of three independent experiments, and error bars indicate standard deviations. (D) Images of DiO-labeled
cardiolipin-containing liposomes (green) and DiI-labeled cardiolipin-containing liposomes (red) in the presence of OPA1-S1 mutant alleles, assayed as in
Fig. 3H. Scale bars are 10 mm.
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liposomes were directly added to the protein solution at a final
concentration of 0.2 mg/ml and incubated at room temperature
for 30 min. Samples (80 ml) were centrifuged at 100 000g
(50 000 rpm in a TLA100 rotor, Beckman Coulter, Inc., Full-
erton, CA, USA) for 15 min at 48C. The supernatant and pellet
were analyzed by SDS–PAGE.
Crosslinking assay
OPA1-S1 was dialyzed at 48C overnight against 50 mM
HEPES (pH 7.0), 300 mM NaCl and 1 mM DTT. OPA1-S1
was added at a final concentration of 0.3 to 0.3 mg/ml PC-
or cardiolipin-containing liposomes and incubated for 30 min
at room temperature. The amine-reactive crosslinker bis(sulfo-
succinimidyl)suberate (BS3; Thermo Fisher Scientific,
Waltham, MA, USA) was added (50 mM final) to the
OPA1-S1–liposome mixture. After a 15 min incubation at
room temperature, the crosslinking reaction was quenched
with 50 mM Tris (pH 8.0). Crosslinked products were analyzed
using a 3–8% Tris–acetate gel (NuPage Novel; Invitrogen,
Carlsbad, CA, USA).
Transmission electron microscopy and cryo-electron
microscopy
OPA1-S1 samples were reconstituted with large multilamellar
cardiolipin-containing liposomes at room temperature. For
negative stain analysis, aliquots of the reaction mixture were
applied to carbon-Formvar coated 400 MESH copper grids
and stained with a 2% (w/v) uranyl acetate solution. Images
were acquired using a transmission electron microscope
(Philips/FEI CM120, Eindhoven, the Netherlands) at 100 kV
and recorded on a CCD camera (GATAN, Pleasanton, CA,
USA). For cryo-electron microscopy, samples were applied
to Quantifoil R 3.5/1 grids (SPI, West Chester, PA, USA),
blotted and plunged into liquid ethane using a Vitrobot appar-
atus (FEI, Eindhoven, the Netherlands). Samples were exam-
ined at cryogenic conditions using a Gatan 626 cryo-holder
in a CM120 microscope, and images were recorded on a
Gatan CCD camera.
Analysis of OPA1 activity in cells
The ability of OPA1 mutants to rescue the fragmented mito-
chondria of OPA1-null MEFs was performed as described pre-
viously (4). Briefly, OPA1-null cells expressing mitochondrial
DsRed were infected with retrovirus-expressing mutant OPA1
alleles and plated onto glass coverslips. Mitochondrial pheno-
types were scored by fluorescence microcopy into four classes
as detailed previously (4).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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